Update on QuiaPEG Transaction
![](https://tracker.live.rns-distribution.com/track.live-rns/5279401_d9353a075fe0b610698e373da828b7e4.png)
24 July 2024
NET ZERO INFRASTRUCTURE PLC
("NZI" or the "Company")
Update on QuiaPEG Transaction
Net Zero Infrastructure Plc, a special purpose acquisition company formed with the intention to acquire renewable or clean energy technology companies and to finance, develop and promote those environmentally sound projects internationally, is pleased to announce an update on the license agreement with QuiaPEG. The agreement will now also include, in addition to the current projects QPG-1029 and QPG-1030, the development opportunity and related IP regarding administering peg-liraglutide on a patch, instead of a daily injection, hence potentially creating an easy-to-administer long-term treatment against obesity.
Enquiries:
For further information, please visit - www.nziplc.com
Contact Details
Net Zero Infrastructure plc Mike Ellwood - Non-Executive Chairman | +44 (0) 799 932 9382 |
Axis Capital Markets Limited (Company Broker) Richard Hutchison | +44 (0) 203 026 0320 |
IFC Advisory (Financial PR) Graham Herring Tim Metcalfe
| +44 (0) 203 934 6630 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.